Open access · CC-BY
via OpenAlex
The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications
Nathan Basisty, Abhijit Kale, Sandip Kumar Patel, Judith Campisi, Birgit Schilling
Expert Review of Proteomics · 2020 · ▲ 69 citations
Abstract
INTRODUCTION: Cellular senescence(definition) is a rapidly growing field with potential relevance for the treatment of multiple human diseases. In the last decade, cellular senescence and the senescence-associated secretory phenotype (SASP) have emerged as central drivers of aging and many chronic diseases, including cancer, neurodegeneration, heart disease and osteoarthritis. Major efforts are underway to develop drugs that selectively eliminate senescent cells (senolytics(definition)) or alter the SASP (senomorphics) to treat age-related diseases in humans. The translation of senescence-targeting therapies into humans is still in early stages. Nonetheless, it is clear that proteomic approaches will facilitate the discovery of important SASP proteins, development of senescence- and SASP-derived biomarkers, and identification of therapeutic targets for senolytic and senomorphic drugs. AREAS COVERED: We review recent proteomic studies of cellular senescence and their translational relevance and, particularly, characterization of the secretory phenotype and preclinical development of biomarkers (from 2008-2020, PubMed). We focus on emerging areas, such as the heterogeneity of senescent cells and the SASP, extracellular vesicles released by senescent cells, and validating biomarkers of aging in vivo. EXPERT OPINION: Proteomic and multi-omic approaches will be important for the development of senescence-based biomarkers to facilitate and monitor future therapeutic interventions that target senescent cells.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1080/14789450.2020.1766976
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Basisty, N., Kale, A., Patel, S.K., Campisi, J., & Schilling, B. (2020). The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications. <em>Expert Review of Proteomics</em>. https://doi.org/10.1080/14789450.2020.1766976
Vancouver
Basisty N, Kale A, Patel SK, Campisi J, Schilling B. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications. Expert Review of Proteomics. 2020. doi:10.1080/14789450.2020.1766976.
BibTeX
@article{nathan2020Thepow,
title = {The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications},
author = {Nathan Basisty and Abhijit Kale and Sandip Kumar Patel and Judith Campisi and Birgit Schilling},
journal = {Expert Review of Proteomics},
year = {2020},
doi = {10.1080/14789450.2020.1766976},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biology 2023
Open access · CC-BY
Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
Journal of Translational Internal Medicine 2025
Open access · CC-BY
Senescent cells as a target for anti-aging interventions: From senolytics to immune therapies
Journal of Student Research 2023
Open access · CC-BY
The Aging of Cells: Cellular Senescence and Implications for Age-Related Diseases
Cells 2021
Open access · CC-BY
Senescent Cells in Cancer: Wanted or Unwanted Citizens
The Gerontologist 2016
Citation only
INTERVENTIONS TARGETING CELLULAR SENESCENCE: THE PATH TO TRANSLATION
Genes & Development 2020
Preprint · CC-BY